1449781-58-1

Basic information

• Product Name: ethyl 2-(1r,4r)-(4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclohexyl)acetate
• Synonyms: ethyl 2-(1r,4r)-(4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclohexyl)acetate
• CAS NO: 1449781-58-1
• Molecular Weight: 372.313
• Mol File: 1449781-58-1.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: ethyl 2-(1r,4r)-(4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclohexyl)acetate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 2-(1r,4r)-(4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclohexyl)acetate(1449781-58-1)
• EPA Substance Registry System: ethyl 2-(1r,4r)-(4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclohexyl)acetate(1449781-58-1)

Safety Data

• Hazardous Substances Data: 1449781-58-1(Hazardous Substances Data)

Upstream product

• 1237147-89-5 4-[(4-hydroxyphenyl)cyclohexylidene]acetic acid ethyl ester 
• 73183-34-3 bis(pinacol)diborane 
• 1449781-57-0 ethyl 2-((1r,4r)-4-(4-hydroxyphenyl)cyclohexyl)acetate 
• 105640-07-1 4-(4-hydroxyphenyl)cyclohexan-1-one 

Downstream Products

• 1449780-89-5 ethyl 2-((1r,4r)-4-(4-(2-((4-(trifluoromethoxy)benzyl)carbamoyl)imidazo[1,2-a]pyridin-6-yl)phenyl)cyclohexyl)acetate 
• 1449780-88-4 ethyl 2-methyl-2-((1r,4r)-4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclohexyl)propanoate 

Relevant articles and documents

COMPOUNDS AS INHIBITORS OF DIACYLGLYCEROL O-ACYLTRANSFERASE TYPE 1 ENZYME

The invention provides a novel compound having activity against diacylglycerol O-acyltransferase type 1 (DGAT1); a pharmaceutical composition for preventing or treating a disease, disorder or condition modulated by inhibition of DGAT1 comprising said compound; a method for preventing or treating a disease, disorder or condition modulated by inhibition of DGAT1 in an individual comprising administering said compound to the individual in need thereof; and a use of said compound for the manufacture of a medicament for preventing or treating a disease, disorder or condition modulated by DGAT1 inhibition.